How Shared Clinical Decision-Making Can Shape the Metastatic Prostate Cancer Journey
When a patient learns they have metastatic castration-sensitive prostate cancer (mCSPC), it often marks the beginning of a long and uncertain journey. The first conversations that follow can shape how that patient feels about their treatment and their role in it. In those early moments, how we respond matters.
Metastatic castration-sensitive prostate cancer (mCSPC) marks a challenging journey for patients. Early conversations with healthcare providers play a crucial role in shaping a patient's experience and adherence to treatment. While prostate cancer affects a significant portion of men, mCSPC accounts for a smaller percentage of annual cases in the United States.
The diagnostic process often involves imaging tests to determine the extent of metastasis, leading to a diagnostic window where patients need to process the diagnosis and their role in the treatment journey.
Shared clinical decision-making is essential, as it allows patients to feel well-informed and engaged in their care. However, balancing urgency with optimism is crucial. Timing is critical, as patients may not always be symptomatic at diagnosis. Building a trusted relationship with patients during this diagnostic window is vital to establish open communication and understanding.
Shared clinical decision-making is not about relinquishing medical expertise but about expanding the conversation to encompass the patient's real-world circumstances. Patients' concerns, such as difficulty swallowing pills, can significantly impact medication adherence and overall survival. Gathering this information is essential for personalized treatment plans.
Real-world evidence (RWE) can provide valuable insights into medication performance and usage in everyday clinical practice, complementing traditional randomized clinical trials (RCTs) that often lack diversity. By incorporating RWE, healthcare providers can make more informed treatment decisions and support shared decision-making, ultimately improving patient outcomes.
Written by urgent.news from Fierce Healthcare's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
